Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Twinrix vs Engerix-B for Hepatitis B Seroprotection in Hemodialysis Patients
NCT00186836Phase 4Completed
- Sponsor
- St. Joseph's Health Care London
- Start
- Nov 2004
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of hepatitis b vaccine recombinant in hepatitis B (HBV) (2 arms), sponsored by St. Joseph's Health Care London. Primary endpoint: Hepatitis B antibody response at month 7. Started Nov 2004; status: completed.
02
Drugs
hepatitis b vaccine recombinant
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00186836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00186836.